surge

Surge is a circuit breaker for the nervous system, provisioned by clinicians. It is a crisis utility, not a wellness app.

It runs on a single mathematical decay curve. One curve drives everything a person sees, hears, and feels, carrying a dysregulated nervous system back toward a regulated state in as little as ninety seconds, before clinical work begins.

Surge is the studio's B2B clinical product. Providers license it and provision anonymous tokens to patients. It is the clearest proof point in the portfolio for the custom-build practice, because it carries real clinical and billing complexity. Surge stands apart from the two product lines as the studio's clinical instrument.

martori studio runs two engines. consulting and custom builds are the primary business. the portfolio of ten products, across the healing-worlds and tools lines, is the second engine: proof of work and a sales asset, not the revenue center. surge stands apart from both lines as the clinical instrument. the practice sells one thing: a free listening, then the sketch, then the $500 build day. the old tier ladder is retired.

Surge is the studio's strongest custom-build proof point. A clinical B2B product with a billing-code pathway is the hardest thing on the shelf to build, which makes it the most persuasive thing to show a prospective client.

Surge ships three sequences, each derived from the same engine.

instant reset, 30s

a physiological sigh, with an orange-to-indigo hard cut at ten seconds.

orienting anchor, 60s

bilateral grounding, a terracotta-to-sage gradient, an active tap.

coherence ripple, 90s

the original. press and hold, deep forest and ocean.

All three route to an aftermath view and an opt-in handoff to Heron. The engine is offline-resilient, because a crisis never waits on a network.

Clinical, and human. Surge speaks with physiological specificity, not the vocabulary of self-care. It describes what the body is doing, plainly.

Never a promise of reimbursement. The RTM pathway is real, but eligibility is the provider's billing team to confirm. Surge never states or implies that a claim will be paid.

The three bans, studio-wide. No em dashes. No exclamation points. No wellness language. This last one is load-bearing for Surge, which is a crisis utility and must never read as a wellness product.

One typeface. Hanken Grotesk, weights 400 to 800, no exceptions.

Dark-first, on true black. Clay is the accent and the studio signature. A sage green marks the regulated, resting state the curve settles into.

The mark. the decay-curve logomark, Direction B: a sharp asymmetric peak, a long settle to a single rest dot, and no drawn baseline. the martori gate is the studio mark.

Surge carries two companions. Crane works in the moment, inside the decompression view, guiding a sequence in real time. Heron works after, in the aftermath view, helping a person understand what their body just did and build awareness over time.

Crane defaults to a 24-hour ephemeral session with a quiet opt-in for local persistence. Anonymous free users never transmit data, which holds the zero-identity-harvesting promise. Presence, not retention.

A crisis utility, not a wellness app. This is the line the whole product defends. Every word and every pixel keeps it.

One curve. a single decay drives visual, audio, and haptic together. the engine is the brand.

Two tracks, kept separate. Track one is the clinical tool, which sells at launch on outcomes with no regulatory dependency. Track two is the billable device, which requires FDA device-positioning and clinical and legal review before anyone pitches reimbursement.

B2B only. providers pay and provision. patients enter through an anonymous token. that structure is the privacy promise made concrete.

No product in this portfolio sells another one to a patient. Pull request 85 shipped a Purpose Driven Collection cross-sell and added Vigil to it. The studio retired cross-product funneling when the flywheel was reframed as proof to consulting, and the parent book puts it plainly: the craft carries from one build to the next, a person never does. Nowhere is that rule stricter than here. A person reaches Surge in the worst ninety seconds of their week, holding a token from a clinician who is responsible for them. That is a patient, not an audience. Offering grief software to someone coming out of a panic episode is a guess about their life that nobody has earned the right to make. Where the collection renders decides how serious this is: a marketing page is a doctrine problem, the provider portal is a partner problem, and the patient session is a clinical one. It does not belong in the patient session. And if Track two ever bills RTM, a reimbursed clinical touchpoint carrying a cross-sell stops being a matter of taste.

1. one face. hanken grotesk, 400 to 800, everywhere.
2. clay #b6502e is the accent and the studio signature. the gate is the studio mark.
3. dark-first, on true black.
4. no em dashes. no exclamation points. no wellness language.
5. a crisis utility, not a wellness app. never blur the line.
6. never promise reimbursement. eligibility is the provider's billing team to confirm.
7. B2B only, with zero identity harvesting for anonymous users.
8. no product sells another one to a patient. the craft carries from one build to the next, a person never does.
9. ship on readiness, not on a date.